Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters

BACKGROUND: Hand-foot syndrome (HFS) is a side effect of skin related to pegylated liposomal doxorubicin (PLD) application. Moderate to severe hand-foot syndrome (MSHFS) might have a serious impact on patients’ quality of life and treatment. However, information on risk factors for the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Guohua, Ma, Wenjie, Zhao, Yanfang, Liu, Eryu, Shan, Xiaoyu, Ma, Weiwei, Tang, Dabei, Li, Liru, Niu, Xingjian, Zhao, Wenhui, Zhang, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025507/
https://www.ncbi.nlm.nih.gov/pubmed/33827689
http://dx.doi.org/10.1186/s12885-021-08028-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025507/
https://www.ncbi.nlm.nih.gov/pubmed/33827689
http://dx.doi.org/10.1186/s12885-021-08028-8

Ejemplares similares